According to a new report Global Bone Growth Stimulators Market, published by KBV research, The Global Bone Growth Stimulators Market size is expected to reach $1.7 billion by 2026, rising at a market growth of 7.1% CAGR during the forecast period. Globally, the rising prevalence of arthritis is a key factor leading to market growth. Rising prevalence of arthritis due to aging and obesity are the main factors leading to the growth of the industry. The elderly are more vulnerable to osteoarthritis and gouty arthritis. An increasing number of injuries and accident cases is considered to be one of the high impact drivers likely to increase demand for the products.
The BMP (Bone Morphogenetic Proteins) and PRP (Platelet-Rich Plasma) segments are expected to show lucrative growth over the forecast period due to a growing occurrence of arthritis, spinal injuries and trauma, and accidents. Additionally, The Platelet-Rich Plasma market is expected to witness highest CAGR of 10.2% during (2020 - 2026).
Hospitals and clinics hold the largest market share due to increased admission of patients suffering from serious injuries, traffic collisions, spinal injuries, and fractures. As a result, this segment dominated the market in 2019 due to fast patient turnover and regular referrals for surgery and other treatments. The home care segment is expected to show lucrative growth during the forecast period due to product advancements and an increase in people's health awareness. Such tools are lightweight and compact and can be comfortably operated by patients at home for the treatment of arthritis, fractures, acute and chronic pain, and osteoporosis.
North America dominated the bone growth stimulation market with the highest revenue share due to a high incidence of osteoporosis or vertebral fractures. Europe was the second-largest region in the bone growth stimulators market due to the high demand for innovative chronic disease therapies and the local presence of leading manufacturers of medical devices such as Medtronic; Orthofix Holdings, Inc.; Zimmer Biomet; Bioventus; Stryker; and Terumo BCT, Inc. Additionally, The Asia Pacific market is poised to grow at a CAGR of 8.4% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/bone-growth-stimulators-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson and Johnson, Medtronic PLC, Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew PLC, Terumo Corporation (Terumo BCT, Inc.), Colfax Corporation (DJO Global, Inc.), Orthofix Medical, Inc., Arthrex, Inc., Bioventus LLC.
By Product
By Application
By Distribution Channel
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
